Children need champions. Get involved, speak out, volunteer, or become a donor and give every child a fair chance to succeed.
Library Home | Reset filters
Select one or more filter options and click search below.
Reset filters
AUTHOR(S) Robert S. Olick; Y. Tony Yang; Jana Shaw (et al.)
AUTHOR(S) Leena R. Baghdadi; Marwah M. Hassounah; Afnan Younis (et al.)
AUTHOR(S) Xiao Wan; Haitao Huang; Jia Shang (et al.)
AUTHOR(S) Divakar Sharma
The COVID-19 pandemic is a globalized health concern caused by a beta-coronavirus named Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Since December 2019, when this outbreak flared in Wuhan, China, COVID-19 cases have been continuously rising all over the world. Due to the emergence of SARS-CoV-2 mutants, subsequent waves are flowing in a faster manner as compared to the primary wave, which is more contagious and causing higher mortality. Recently, India has emerged as the new epicenter of the second wave by mutants of SARS-CoV-2. After almost eighteen months of this outbreak, some COVID-19 dedicated therapeutics and vaccines are available, and a few are under trial, but the situation is still uncontrolled. This perspective article covers the repurposing of childhood vaccines like Bacille Calmette–Guerin (BCG), Measles, Mumps, Rubella (MMR), and Oral Polio Vaccine (OPV), which are live attenuated vaccines and have been shown the protective effect through ‘trained immunity and ‘crossreactivity.'
AUTHOR(S) Soo-Han Choi; Yoon Hee Jo; Kyo Jin Jo (et al.)
Coronavirus disease 2019 (COVID-19) vaccination is necessary to reach herd immunity and essential for mitigating the spread of the pandemic. In May 2021, the US FDA and the EU have expanded the emergency use authorization for a COVID-19 vaccine to children aged 12 to 15. The aim of this study was to investigate parental acceptability of COVID-19 vaccination for their children, factors affecting their acceptability, and children's perceptions of COVID-19 vaccines in Republic of Korea. A questionnaire survey at two tertiary hospitals was conducted from May 25, 2021 to June 3, 2021. Subjects were parents having children under 18 years and children aged 10–18 years.
AUTHOR(S) Simon R. Procter; Kaja Abbas; Stefan Flasche (et al.)
The COVID-19 pandemic has disrupted the delivery of immunisation services globally. Many countries have postponed vaccination campaigns out of concern about infection risks to the staff delivering vaccination, the children being vaccinated, and their families. The World Health Organization recommends considering both the benefit of preventive campaigns and the risk of SARS-CoV-2 transmission when making decisions about campaigns during COVID-19 outbreaks, but there has been little quantification of the risks. This study modelled excess SARS-CoV-2 infection risk to vaccinators, vaccinees, and their caregivers resulting from vaccination campaigns delivered during a COVID-19 epidemic. It used population age structure and contact patterns from three exemplar countries (Burkina Faso, Ethiopia, and Brazil). It combined an existing compartmental transmission model of an underlying COVID-19 epidemic with a Reed-Frost model of SARS-CoV-2 infection risk to vaccinators and vaccinees. It explored how excess risk depends on key parameters governing SARS-CoV-2 transmissibility, and aspects of campaign delivery such as campaign duration, number of vaccinations, and effectiveness of personal protective equipment (PPE) and symptomatic screening.
AUTHOR(S) Faith Agbozo; Albrecht Jahn
AUTHOR(S) José Moreno-Montoya; Silvia Marcela Ballesteros; Jaid Constanza Rojas Sotelo (et al.)
This article aims to assess the impact of the COVID-19 pandemic on routine childhood vaccination coverage in Colombia by age group, rural/urban residence, state and vaccine type. It is an ecological study of official monthly vaccination records.
AUTHOR(S) Chloe A. Teasdale; Luisa N. Borrell; Yanhan Shen (et al.)
AUTHOR(S) Kaidi He; Wendy J. Mack; Michael Neely (et al.)
AUTHOR(S) Tom Woudenberg; Stephane Pelleau; Francois Anna (et al.)
AUTHOR(S) Beate Kampmann; Uduak Okomo
AUTHOR(S) Katy Lillie
AUTHOR(S) Adin Breuer; Allon Raphael; Hagay Stern (et al.)
This study evaluated the prevalence of paediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections using antibody testing and characterised antibody titres by time from exposure. This was a single-centre, prospective, cross-sectional cohort study. Patients under 18 years old were eligible to participate if they attended the paediatric emergency department at the tertiary Shaare Zedek Medical Center, Jerusalem, Israel, from 18 October 2020 to 12 January 2021 and required blood tests or intravenous access. SARS-CoV-2 seropositivity and antibody levels were tested by a dual-assay model.
AUTHOR(S) S. Bookstein Peretz; N. Regev; L. Novick (et al.)
This study aims to determine the immunogenicity and reactogenicity of Pfizer's BNT162b2 COVID-19 vaccine among pregnant women compared with non-pregnant women, and to evaluate the obstetric outcome following vaccination. An observational case-control study of pregnant women, who were vaccinated by a 2-dose regimen of BNT162b2 vaccine during gestation between January-February 2021 (study group) and were compared to age-matched non-pregnant women who received the vaccine during the same time period (control group).
UNICEF Innocenti's Children and COVID-19 Library is a database collecting research from around the world on COVID-19 and its impacts on children and adolescents.
Read the latest quarterly digest on violence against children and women during COVID-19.
The first digest covers children and youth mental health under COVID-19.
Subscribe to updates on new research about COVID-19 & children
COVID-19 & Children: Rapid Research Response
